Split Decision In Breach-of-Contract Battle Of Litigation War Between ChromaDex, Elysium
Consolidated Advertising Complaints Continue, ChromaDex Appeals Patent-Infringement Loss
California federal court jury found both breached contracts: Elysium failed to pay for nicotinamide riboside and pterostilbene it ordered and received, while ChromaDex violated pricing provision in supply agreement.
